about
DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriersRed meat and poultry, cooking practices, genetic susceptibility and risk of prostate cancer: results from a multiethnic case-control studyGenome-wide association studies identify four ER negative-specific breast cancer risk lociThe Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancerGenome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer riskRare mutations in RINT1 predispose carriers to breast and Lynch syndrome-spectrum cancersRare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening studyGenome-wide scan of 29,141 African Americans finds no evidence of directional selection since admixtureRare, evolutionarily unlikely missense substitutions in CHEK2 contribute to breast cancer susceptibility: results from a breast cancer family registry case-control mutation-screening studyIdentification of seven new prostate cancer susceptibility loci through a genome-wide association studyA genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association studyIdentification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European DescentIdentification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study.Variation in genes related to obesity, weight, and weight change and risk of contralateral breast cancer in the WECARE Study population.A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry.Body mass index and risk of second primary breast cancer: the WECARE Study.The landscape of recombination in African Americans.Enhanced statistical tests for GWAS in admixed populations: assessment using African Americans from CARe and a Breast Cancer Consortium.Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium.Alcohol consumption and survival after a breast cancer diagnosis: a literature-based meta-analysis and collaborative analysis of data for 29,239 cases.Methodological Considerations in Estimation of Phenotype Heritability Using Genome-Wide SNP Data, Illustrated by an Analysis of the Heritability of Height in a Large Sample of African Ancestry Adults.Identification, replication, and fine-mapping of Loci associated with adult height in individuals of african ancestry.Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2.Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)Admixture mapping of 15,280 African Americans identifies obesity susceptibility loci on chromosomes 5 and X.Diagnostic chest X-rays and breast cancer risk before age 50 years for BRCA1 and BRCA2 mutation carriers.Impact of neighborhood and individual socioeconomic status on survival after breast cancer varies by race/ethnicity: the Neighborhood and Breast Cancer Study.Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation CarriersMeta-analysis of loci associated with age at natural menopause in African-American womenTotal energy intake and breast cancer risk in sisters: the Breast Cancer Family RegistryThe potential for enhancing the power of genetic association studies in African Americans through the reuse of existing genotype data.Recent changes in breast cancer incidence and risk factor prevalence in San Francisco Bay area and California women: 1988 to 2004.Heterogeneity of breast cancer subtypes and survival among Hispanic women with invasive breast cancer in California.The California Breast Cancer Survivorship Consortium (CBCSC): prognostic factors associated with racial/ethnic differences in breast cancer survivalA functionally significant SNP in TP53 and breast cancer risk in African-American womenCommon genetic variants and modification of penetrance of BRCA2-associated breast cancerEuropean ancestry is positively associated with breast cancer risk in Mexican women
P50
Q21144874-B4835610-EAB6-4058-8AE4-255307D7BC29Q24614203-3A56BEA9-003C-4ABC-948B-D4821D00F6EEQ24622610-1ED72552-2B08-4827-A4FF-30C2A5E2515AQ24806109-18FAD381-38C7-401C-901B-D17CB73F36BEQ27008356-0F93781F-EB8A-4C22-AF0B-E8E0E10420C7Q28652056-3008296D-DA21-436A-B99B-7EFB64C49142Q28652308-EE637363-CBEB-4108-B1AE-722B170F7364Q28655044-DEB3407A-B9A3-40B3-9548-4B77D8E01B50Q28743906-7080966F-889F-4FC8-9523-35790A61933EQ29417022-BCE8FFE8-BA90-4517-BF00-8AC0944D349EQ29417036-3C9EE5E8-7D20-4A0B-A7F4-1096181EC015Q29417074-3FC1104E-859B-4200-B9C4-35F4A3D21BB6Q29417155-D6CF050A-5292-4464-80E5-1FB0CAA5B497Q30000080-59B3E3C4-C774-4F03-A8A5-3967B66792F5Q30252854-8145538D-A6F8-4C13-A41A-C0CDABD4E07CQ30415050-B745FC04-995C-4D97-8AAA-0B9EC412D5E3Q30416002-009ED54F-D9F8-471C-83FD-80DD514CEFC5Q30416161-477A2237-3B07-48AB-815A-4F2985CF9851Q30423088-50D1A21A-F30B-4ECF-AB32-D1371A523D2DQ30428393-6EB40D1A-BA15-487B-9460-157353C89128Q30432415-5E08EA82-074C-4B42-AF31-5129819EB705Q30491647-66386CE8-B8BC-4985-BB4F-BFC73178A43DQ30779634-A2737BAF-24BD-4580-B288-BCDF651A5303Q30977635-828C10F4-524E-4FCD-B06D-9F435A7F44A3Q31036626-C1FB4E97-6726-42C9-A424-08C152140D22Q31043651-264ACAFE-2F8F-4796-AECF-C3F3BA10FA1AQ31082788-A7235328-36EA-4A60-8C3B-2352DD0C411AQ33450573-A7510AB5-7750-4735-A80D-44850819D7EBQ33588213-2E8890E4-D5CE-462D-860A-CB7617319346Q33599178-CDE6E06F-1066-4025-93F9-7BEBA2433EB7Q33614244-BF0DF9E1-A4AE-4D43-B22B-25C6038DCADDQ33649334-EC27EB80-17BA-4C37-8940-7ACDE8CBA720Q33654997-F66E6685-8372-476C-9E71-45C38D9D499CQ33686851-63B28391-E032-4BE4-8C3C-4CA907BD51EEQ33693138-DC7B2629-D3D7-445E-B8FC-90E7E7D16C29Q33709421-C1100AE1-6F36-4578-B3E0-82184702BA53Q33716455-40B2B0E4-BBFA-42B7-ACFD-429E034B4D74Q33731355-A86F7FE5-03B5-4F42-A461-E92B9C291972Q33742096-9DF10C0C-0570-4E7A-A898-D8A81B3B9365Q33780831-F545FB26-69F4-4AA3-BFCC-DAC5E22F9E32
P50
description
kreftforsker
@nb
onderzoeker
@nl
researcher ORCID ID = 0000-0003-3259-8003
@en
name
Esther John
@ast
Esther John
@es
Esther John
@nl
Esther M. John
@da
Esther M. John
@de
Esther M. John
@en
Esther M. John
@fr
Esther M. John
@nb
Esther M. John
@nn
Esther M. John
@sv
type
label
Esther John
@ast
Esther John
@es
Esther John
@nl
Esther M. John
@da
Esther M. John
@de
Esther M. John
@en
Esther M. John
@fr
Esther M. John
@nb
Esther M. John
@nn
Esther M. John
@sv
altLabel
Esther John
@en
prefLabel
Esther John
@ast
Esther John
@es
Esther John
@nl
Esther M. John
@da
Esther M. John
@de
Esther M. John
@en
Esther M. John
@fr
Esther M. John
@nb
Esther M. John
@nn
Esther M. John
@sv
P106
P31
P496
0000-0003-3259-8003